Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A.

[1]  J. H. Herman,et al.  Cytokine modulation of chondrocyte proteinase release. , 1984, Arthritis and rheumatism.

[2]  L. Noel,et al.  Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice. , 1983, Clinical and experimental immunology.

[3]  Green Cj.  Immunosuppression with cyclosporin A: a review. , 1981 .

[4]  H. Okudaira,et al.  Anti-double strand (ds) DNA antibody formation by NZB/W (F1) spleen cells in a microculture system detected by solid phase radioimmunoassay. , 1981, Journal of immunological methods.

[5]  M. Röllinghoff,et al.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2 , 1981, European journal of immunology.

[6]  E. Larsson.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. , 1980, Journal of immunology.

[7]  A. Hess,et al.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. , 1980, Journal of immunology.

[8]  R. Calne.  Immunosuppression for Organ Grafting Observations on Cyclosporin A , 1979, Immunological reviews.

[9]  J. Burckhardt,et al.  Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function. , 1979, Immunology.

[10]  G. Pawelec,et al.  CYCLOSPORIN A: AN IMMUNOSUPPRESSIVE AGENT PREFERENTIALLY ACTIVE AGAINST PROLIFERATING T CELLS , 1979, Transplantation.

[11]  J. Borel,et al.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals. , 1977, Immunology.

[12]  D. Lucas.  Regulatory mechanisms in lymphocyte activation , 1977 .

[13]  A. Theofilopoulos,et al.  The Raji cell radioimmune assay for detecting immune complexes in human sera. , 1976, The Journal of clinical investigation.